Celldex Therapeutics reported $230K in Trade Debtors for its fiscal quarter ending in March of 2026.





Trade Debtors Change Date
AbbVie USD 12.59B 180M Dec/2025
Agenus USD 22.44M 1.14M Dec/2025
Amgen USD 9.14B 432M Mar/2026
Bristol-Myers Squibb USD 14.36B 164M Mar/2026
Celldex Therapeutics USD 230K 1.78M Mar/2026
Glaxosmithkline GBP 10.45B 707.81M Dec/2025
Nektar Therapeutics USD 1.78M 1.12M Dec/2025
Northwest Biotherapeutics USD 311K 299K Sep/2025
Pfizer USD 16.17B 332M Mar/2026
Rigel Pharmaceuticals USD 28.9M 1.39M Jun/2024
Roche Holding CHF 11.9B 460M Dec/2025